Skip to main content
In stock|Targeted Therapy

LY3410738 (IDH1/2 Inhibitor)

Oncology TypeHematologic (AML)
Drug Class / MechanismIDH1/2 Inhibitor
No Image
Description

LY3410738 (IDH1/2 Inhibitor) is classified as an IDH1/2 Inhibitor, sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy
Oncology TypeHematologic (AML)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3